Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
46.47
+0.76 (1.65%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Novo Nordisk Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Novo Nordisk stock has a consensus rating of "Hold" and an average price target of $46.89. The average 1-year stock price forecast is 0.91% higher than the current stock price, while the lowest is $39.95 (-14.02%) and the highest is $63.66 (+37.01%).
Price Target: $46.89 (+0.91%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Novo Nordisk stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 9 | 9 | 9 | 10 | 10 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Hold Reiterates $47 | Hold | Reiterates | $47 | +1.15% | Aug 12, 2026 |
| Berenberg Bank | Berenberg Bank | Hold Downgrades $50 → $47 | Hold | Downgrades | $50 → $47 | +1.15% | Aug 12, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $48 → $44 | Hold | Maintains | $48 → $44 | -5.31% | Aug 7, 2026 |
| Argus Research | Argus Research | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 7, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $42 | Hold | Maintains | $42 | -9.61% | Jun 29, 2026 |
Financial Forecast
Revenue This Year
297.87B
from 309.06B
Decreased by -3.62%
Revenue Next Year
304.87B
from 297.87B
Increased by 2.35%
EPS This Year
21.37
from 23.03
Decreased by -7.21%
EPS Next Year
21.88
from 21.37
Increased by 2.39%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.